Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19

[1]  P. Wilson,et al.  Remembering seasonal coronaviruses , 2020, Science.

[2]  S. Ciesek,et al.  Analysis of humoral immune responses in SARS-CoV-2 infected patients , 2020, The Journal of infectious diseases.

[3]  M. Dugas,et al.  Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1) , 2020, International Journal of Infectious Diseases.

[4]  T. Puthanakit,et al.  Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019 , 2020, PloS one.

[5]  N. Miller,et al.  Recent endemic coronavirus infection is associated with less severe COVID-19. , 2020, The Journal of clinical investigation.

[6]  N. Hacohen,et al.  Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity , 2020, Science.

[7]  P. Doshi.  Covid-19: Do many people have pre-existing immunity? , 2020, BMJ.

[8]  M. Dugas,et al.  Association of contact to small children with a mild course of COVID-19 , 2020, International Journal of Infectious Diseases.

[9]  S. Mallal,et al.  Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans , 2020, Science.

[10]  M. Dugas,et al.  Association of contact to small children with mild course of COVID-19 , 2020, medRxiv.

[11]  Martin Linster,et al.  SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls , 2020, Nature.

[12]  Liyan Wen,et al.  Kinetics of viral load and antibody response in relation to COVID-19 severity. , 2020, The Journal of clinical investigation.

[13]  J. Greenbaum,et al.  Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals , 2020, Cell.

[14]  Christopher Earl,et al.  Preexisting and de novo humoral immunity to SARS-CoV-2 in humans , 2020, Science.

[15]  P. Adab,et al.  Covid-19: risk factors for severe disease and death , 2020, BMJ.

[16]  J. Ludvigsson.  Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults , 2020, Acta paediatrica.

[17]  Yonatan H. Grad,et al.  Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.

[18]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[19]  C. Gleasner,et al.  A metagenomic viral discovery approach identifies potential zoonotic and novel mammalian viruses in Neoromicia bats within South Africa , 2018, PloS one.